61. Search Result For "Anemia, Hemolytic" DrugInduced hemolytic anemia; hemolytic anemia; hemolytic anemia; About Anemia; Anemia; Aplastic Anemia; hemolytic anemia; Iron Deficiency Anemia; http://www.noah-health.org/search/results.php?lang=1&keyword=Anemia, Hemolytic&d

62. Immune-Mediated Hemolytic Anemia -- Rosse Et Al. 2004 (1): 48 -- Hematology hemolytic anemia due to immune function is one of the major causes of acquired PNH is unique because it is an acquired hemolytic anemia due to an http://www.asheducationbook.org/cgi/content/full/2004/1/48

HOME HELP FEEDBACK SUBSCRIPTIONS ... TABLE OF CONTENTS QUICK SEARCH: [advanced] Author: Keyword(s): Year: Vol: Page: This Article Abstract Full Text (PDF) Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager PubMed PubMed Citation Articles by Rosse, W. F. Articles by Schreiber, A. D. Hematology 2004 The American Society of Hematology Immune-Mediated Hemolytic Anemia Wendell F. Rosse Peter Hillmen and Alan D. Schreiber Abstract Hemolytic anemia due to immune function is one of the major causes of acquired hemolytic anemia. In recent years, as more is known about the immune system, these entities have become better understood and their treatment improved. In this section, we will discuss three areas in which this progress has been apparent. In Section I, Dr. Peter Hillmen outlines the recent findings in the pathogenesis of paroxysmal nocturnal hemoglobinuria (PNH), relating the biochemical defect (the lack of glycosylphosphatidylinositol [GPI]-linked proteins on the cell surface) to the clinical manifestations

63. Hemolytic Anemia hemolytic anemia However, if left untreated, hemolytic anemia can lead to heart failure or liver complications. Prevention. hemolytic anemia due to http://www.healthatoz.com/healthatoz/Atoz/ency/hemolytic_anemia.jsp

64. ASHP News: Psoriasis Treatment Linked To Hemolytic Anemia Two of the patients were diagnosed with hemolytic anemia while participating in No case of hemolytic anemia, the result of redblood-cell destruction, http://www.ashp.org/news/ShowArticle.cfm?id=11757

65. Hemolytic Anemia: Definition And Much More From Answers.com hemolytic anemia n. Anemia resulting from the lysis of red blood cells, as in response to certain toxic or infectious agents and in certain inherited. http://www.answers.com/topic/hemolysis-1

showHide_TellMeAbout2('false'); Business Entertainment Games Health ... More... On this page: Dictionary Medical WordNet Wikipedia Mentioned In Or search: - The Web - Images - News - Blogs - Shopping hemolytic anemia Dictionary hemolytic anemia n. Anemia resulting from the lysis of red blood cells, as in response to certain toxic or infectious agents and in certain inherited blood disorders. Medical hemolytic anemia n. Anemia resulting from the abnormal destruction of of red blood cells, as in response to certain toxic or infectious agents and in certain inherited blood disorders. WordNet Note: click on a word meaning below to see its connections and related words. The noun hemolytic anemia has one meaning: Meaning #1 anemia resulting from destruction of erythrocytes Synonym: haemolytic anaemia Wikipedia hemolysis Hemolysis (alternative spelling haemolysis ) is the excessive breakdown of red blood cells . When this happens, it causes a form of anemia Hemolysis is also an important factor in medical tests, as a blood sample may become hemolysed with prolonged storage, or during

66. Hemolytic Anemia Detailed information on aplastic anemia, including cause, symptom, diagnosis, and treatment. http://www.healthsystem.virginia.edu/uvahealth/peds_hematology/hemoanem.cfm

[ Skip Navigation ] Health System Home For Health Answers Healthcare Professionals ... Advanced Search Health System Search Search for Information People UVa Home Health System News Health System Events (all) Health System Publications ... Making a Gift Topics Adolescent Medicine Allergy/Asthma/Immunology Blood Disorders Burns Cancer Common Injuries/Poison Tips Craniofacial Anomalies Dermatology Diabetes/Endo/Metabolism Eye Care Genitourinary/Kidney High-Risk Newborn High-Risk Pregnancy Infectious Diseases Medical Genetics Mental Health Nervous System Disorders Normal Newborns Oral Health Orthopaedics Pediatric Surgery Respiratory Disorders Terminal Illness in Children Transplantation UVa Health Topics A to Z FIND A DOCTOR Pediatric Hematology-Oncology MAKE AN APPOINTMENT CALENDAR OF EVENTS ... CLINICAL TRIALS Search This Site Hemolytic Anemia What is hemolytic anemia? Hemolytic anemia is a disorder in which the red blood cells are destroyed faster than the bone marrow can produce them. The term for destruction of red blood cells is "hemolysis." There are two types of hemolytic anemia: intrinsic - the destruction of the red blood cells due to a defect within the red blood cells themselves. Intrinsic hemolytic anemias are often inherited, such as sickle cell anemia and thalassemia. These conditions produce red blood cells that do not live as long as normal red blood cells.

67. Raptiva Label To Include Hemolytic Anemia Warning - CME Teaching Brief - MedPage Raptiva Label to Include hemolytic anemia Warning psoriasis drug Raptiva (efalizumab) following reports of four cases of hemolytic anemia diagnosed four http://www.medpagetoday.com/ProductAlert/Prescriptions/tb/1393

HOME/LATEST HEADLINES NEWS BY SPECIALTY 2005 Meeting Coverage Cardiovascular Dermatology Endocrinology ... Surgery NEW USERS: REGISTER HERE RETURNING USERS: LOG IN UPDATE YOUR PROFILE CME TRACKER ABOUT MEDPAGE TODAY ... HELP CENTER Raptiva Label to Include Hemolytic Anemia Warning By Neil Osterweil, Senior Associate Editor, MedPage Today July 20, 2005 Also covered by: MSNBC WSJ Online (Subscription Req.) ROCKVILLE, Md., July 20-The FDA announced today new warnings on the Genentech psoriasis drug Raptiva (efalizumab) following reports of four cases of hemolytic anemia diagnosed four to six months after patients started on the monoclonal antibody. Two of the cases occurred in clinical trials of Raptiva, and two were reported as postmarketing events, the FDA said. In a "Dear Healthcare Provider" letter issued July 20, Genentech reported that in two severe cases, hemoglobin levels dropped to 6 and 7 g/dL. "A causal relationship between Raptiva and these events has not been established but cannot be excluded," the letter said. The package insert for Raptiva was amended to include a warning to discontinue the drug should hemolytic anemia occur. In addition, the information sheet has been updated to include in the warnings section news of postmarketing reports of necrotizing fasciitis, tuberculous pneumonia, bacterial sepsis with seeding of distant sites, severe pneumonia with neutropenia, and worsening of infections such as pneumonia despite antimicrobial therapy.

68. Anemia hemolytic anemias Rarely, anemia is due to problems that cause the red blood In hemolytic anemia, this time is shortened, sometimes to only a few days. http://www.labtestsonline.org/understanding/conditions/anemia-3.html

TESTS Test not listed? A/G Ratio ACE ACT ACTH AFB Culture AFP Maternal AFP Tumor Marker Albumin Aldolase Aldosterone Allergies ALP Alpha-1 Antitrypsin ALT Ammonia Amylase ANA Antibody Tests Antiglobulin, Direct Antiglobulin, Indirect Antiphospholipids Antithrombin Apo A Apo B ApoE Genotyping aPTT AST Autoantibodies Bicarbonate Bilirubin Blood Culture Blood Gases Blood Smear BMP BNP Bone Markers BRCA BUN C-peptide CA-125 CA 15-3 CA 19-9 Calcitonin Calcium Cardiac Biomarkers Cardiac Risk Cardiolipin Antibodies Catecholamines CBC CCP C. diff CEA Celiac Disease Tests CF Gene Mutation Chemistry Panels Chlamydia Chloride Cholesterol CK CK-MB CMP CMV Coagulation Factors Complement Levels Cortisol Creatinine Creatinine Clearance CRP CRP, high-sensitivity

69. NORD - National Organization For Rare Disorders, Inc. Synonyms of Anemia, Hereditary Nonspherocytic Hemolytic Hereditary Nonspherocytic hemolytic anemia is a term used to describe a group of rare genetic http://www.rarediseases.org/search/rdbdetail_abstract.html?disname=Anemia, Hered

70. NORD - National Organization For Rare Disorders, Inc. Warm Antibody hemolytic anemia is an autoimmune disorder characterized by the premature As their names imply, Warm Antibody hemolytic anemia occurs at http://www.rarediseases.org/search/rdbdetail_abstract.html?disname=Anemia, Hemol

71. Anemia, Hemolytic, Warm Antibody Warm Antibody hemolytic anemia is an autoimmune disorder characterized by the premature destruction http://webcenter.health.webmd.netscape.com/hw/anemia/nord770.asp

var guid_source = ""; var guid_source_id = ""; //unused var encodedurl = ""; WebMD Today Home WebMD News Center XML News via RSS Member Services WebMD University My WebMD Find a Physician Medical Info Check Symptoms Medical Library Health Tools Clinical Trials ... Women, Men, Lifestyle Who We Are About WebMD Site Map Health Topics Symptoms ... For a Complete Report Anemia, Hemolytic, Warm Antibody Important It is possible that the main title of the report Anemia, Hemolytic, Warm Antibody is not the name you expected. Please check the synonyms listing to find the alternate name(s) and disorder subdivision(s) covered by this report. Synonyms Autoimmune Hemolytic Anemia Warm Reacting Antibody Disease Disorder Subdivisions None General Discussion Warm Antibody Hemolytic Anemia is an autoimmune disorder characterized by the premature destruction of red blood cells by the body's natural defenses against invading organisms (antibodies). Normally, the red blood cells have a life span of approximately 120 days before they are removed by the spleen. In an individual affected with Warm Antibody Hemolytic Anemia, the red blood cells are destroyed prematurely and bone marrow production of new cells can no longer compensate for their loss. The severity of the anemia is determined by the time the red blood cells are allowed to survive and by the capacity of the bone marrow to continue new red blood cell production. Immune Hemolytic Anemias are subdivided by the optimal temperature at which the antibodies destroy red blood cells. As their names imply, Warm Antibody Hemolytic Anemia occurs at temperatures of 37 degrees centigrade or higher while Cold Antibody Hemolytic Anemia usually occurs at approximately to 10 degrees.

72. Diagnosis Of Immune-mediated Hemolytic Anemia Immunemediated hemolytic anemia (IMHA) is an accelerated destruction of red blood It is a common cause of severe anemia and hemolysis in dogs with a http://www.vet.uga.edu/vpp/clerk/hiers/

Diagnosis of Immune-mediated Hemolytic Anemia Kristin M. Hiers, DVM; Kenneth Latimer, DVM, PhD; Perry J. Bain, DVM, PhD; Paula M. Krimer, DVM, DVSc Class of 2003 (Hiers) and Department of Pathology (Latimer, Bain, Krimer), College of Veterinary Medicine, The University of Georgia, Athens, GA 30602-7388 Introduction Immune-mediated hemolytic anemia (IMHA) is an accelerated destruction of red blood cells due to the attachment of immunoglobulin and/or complement to the erythrocyte membrane. It is a common cause of severe anemia and hemolysis in dogs with a mortality rate of over 40%. IMHA can be classified as primary or secondary depending on the cause of the red cell destruction. Secondary IMHA involves hemolysis due to an immunologic reaction to a "non-self" antigen. Possible causes include infection, chemical agents, drugs, or neoplastic disease. Primary IMHA is synonymous with idiopathic and autoimmune-mediated hemolytic anemia (AIHA). There is a true autoantibody specific for the self-antigen of the red cell membrane. Normally the immune system recognizes self-antigen and does not respond to it. This is the principle of self-tolerance. It is thought that when something triggers a change in immunoregulation, such as infection, there may be a loss of self-tolerance and subsequent autoimmune disease. There is a genetic predisposition for the development of AIHA

73. UniProt Knowledgebase Keyword: Hereditary Hemolytic Anemia Protein which, if defective, causes hereditary hemolytic anemia, a hereditary disease characterized by the premature destruction of red blood cells. Synonym http://www.expasy.org/cgi-bin/get-entries?KW=Hereditary hemolytic anemia

74. HEMOLYTIC ANEMIA A person with hemolytic anemia has RBCs that are destroyed or die sooner than they are supposed hemolytic anemia can be a short or long-term problem. http://www.healthtouch.com/bin/EContent_HT/cnoteShowLfts.asp?fname=04003&title=H

75. American Family Physician: Hemolytic Anemia Full text of the article, hemolytic anemia from American Family Physician, a publication in the field of Health Fitness, is provided free of charge by http://www.findarticles.com/p/articles/mi_m3225/is_11_69/ai_n6076523

@import url(/css/us/style1.css); @import url(/css/us/searchResult1.css); @import url(/css/us/articles.css); @import url(/css/us/artHome1.css); Advanced Search Home Help IN free articles only all articles this publication Automotive Sports 10,000,000 articles - not found on any other search engine. FindArticles American Family Physician June 1, 2004 Content provided in partnership with 10,000,000 articles Not found on any other search engine. Featured Titles for AAACN Viewpoint ABNF Journal, The AIDS Treatment News AMAA Journal ... View all titles in this topic Hot New Articles by Topic Automotive Sports Top Articles Ever by Topic Automotive Sports Hemolytic anemia American Family Physician June 1, 2004 by Gurpreet Dhaliwal Patricia A. Cornett Lawrence M. Tierney Save a personal copy of this article and quickly find it again with Furl.net. It's free! Save it. Hemolysis is the destruction or removal of red blood cells from the circulation before their normal life span of 120 days. While hemolysis can be a lifelong asymptomatic condition, it most often presents as anemia when erythrocytosis cannot match the pace of red cell destruction. Hemolysis also can manifest as jaundice, cholelithiasis, or isolated reticulocytosis. Pathophysiology There are two mechanisms of hemolysis. Intravascular hemolysis is the destruction of red blood cells in the circulation with the release of cell contents into the plasma. Mechanical trauma from a damaged endothelium, complement fixation and activation on the cell surface, and infectious agents may cause direct membrane degradation and cell destruction.

76. Indian Journal Of Medical Sciences: Acquired Hemolytic Anemia.(Practitioners Sec Access the article, Acquired hemolytic anemia.(Practitioners section)(Column) from Indian Journal of Medical Sciences, a publication in the field of http://www.findarticles.com/p/articles/mi_hb3298/is_200412/ai_n13066848

@import url(/css/us/style1.css); @import url(/css/us/searchResult1.css); @import url(/css/us/articles.css); @import url(/css/us/artHome1.css); Advanced Search Home Help IN free articles only all articles this publication Automotive Sports 10,000,000 articles - not found on any other search engine. FindArticles Indian Journal of Medical Sciences December 2004 10,000,000 articles Not found on any other search engine. Featured Titles for AAACN Viewpoint ABNF Journal, The AIDS Treatment News AMAA Journal ... View all titles in this topic Hot New Articles by Topic Automotive Sports Top Articles Ever by Topic Automotive Sports Save a personal copy of any page on the Web and quickly find it again with Furl.net. It's free. Get started now. Acquired hemolytic anemia.(Practitioners section)(Column) Indian Journal of Medical Sciences December, 2004 by Shah, Asha Content provided in partnership with Read the full article with a Free Trial of HighBeam Research Byline: Asha. Shah Acquired hemolytic anemia are a group of disorders in which premature destruction of the red cells results from an extra corpuscular abnormality i.e. defect outside the red cell, unlike congenital hemolytic anemia in which the defect is intrinsic to the red cell. Normal compatible red cells transfused to a person with acquired hemolytic anemia are destroyed rapidly but the patients cells transfused to a normal recipient have normal survival. Some of the common acquired hemolytic anemia are discussed below. IDIOPATHIC AUTO-IMMUNE HEMOLYTIC ANEMIA

77. Log In Problems FDA notifies healthcare professionals of postmarketing adverse events related to efalizumab use. http://www.medscape.com/viewarticle/508713

Unable to Deliver Requested Page In order to use Medscape, your browser must be set to accept cookies delivered by the Medscape site. To find out how to adjust your browser settings to accept cookies, please click here Medscape uses cookies to customize the site based on the information we collect at registration. The cookies contain no personally identifiable information and have no effect once you leave the Medscape site. You can read more about our use of cookies in our About Medscape Help WebMD Health

78. Hemolytic Anemia ImmuneMediated hemolytic anemia (IMHA) is a serious and often life threatening disorder in dogs and cats. http://www.gcvs.com/internists/imha.htm

Search for: Search Tips Directions What is Immune-Mediated Hemolytic Anemia? Immune-Mediated Hemolytic Anemia (IMHA) is a serious and often life threatening disorder in dogs and cats. IMHA results from an inappropriate immune response to the animals own red blood cells. IMHA can be classified as primary or secondary. With primary IMHA, the immune system malfunctions and begins to treat the red blood cells as if they were foreign invaders and begins to produce antibodies against the red blood cells. This response is similar to what would occur against bacteria. No underlying cause for this inappropriate reaction can be identified. With secondary IMHA, an underlying disease condition such as infection, parasites, cancer or a reaction to a drug or vaccine causes a change in the red blood cells, which in turn stimulates the immune system to attack the cells. Autoagglutination is often associated with clotting disorders including pulmonary thromboembolism (PTE), which are blood clots in the lungs. Intravascular hemolysis tends to be more severe and carries a worse prognosis than extravascular hemolysis.

79. 7-01 Newsletter IMMUNEMEDIATED hemolytic anemia. July 2001. Immune-mediated hematologic disease including hemolytic anemia (IMHA) and/or thrombocytopenia is being reported http://www.antechdiagnostics.com/clients/antechNews/2001/7-01.htm

IMMUNE-MEDIATED HEMOLYTIC ANEMIA July 2001 Four recent retrospective studies have addressed the clinical and laboratory findings and compared treatment outcomes of dogs with IMHA. In one study of 70 cases, Cocker Spaniels, English Springer Spaniels, Poodles, Miniature Schnauzers, and Collies were at increased risk. Only 3 dogs had been vaccinated within 2 weeks of the diagnosis. Regenerative anemia was present in 83% and 79% had spherocytosis. Only 37% of the dogs had positive Coombs’ test. Thrombocytopenia was also found in 29 dogs. Elevated serum bilirubin concentrations, present in 68% of cases, was significantly associated with decreased survival. A significant difference in survival was found between treatment groups (see Table). The overall mortality was 70%. While 29 dogs died or were euthanized during hospitalization, 41 were discharged but 15 died, most within 3 months of discharge. Dogs with IMHA were four times more likely to die than dogs in the general hospital population. The third study included 88 dogs. Twenty-six dogs received only prednisone. Of these, 15 (58%) survived to be discharged, and the mortality rate was 30%. The relative risk of death for dogs treated

80. Anemia, Hemolytic, Cold Antibody Cold Antibody hemolytic anemia is a rare autoimmune disorder characterized by the premature destruction of red blood cells by the body s natural defenses http://www.bchealthguide.org/kbase/nord/nord723.htm

var hwPrint=1;var hwDocHWID="nord723";var hwDocTitle="Anemia, Hemolytic, Cold Antibody";var hwRank="1";var hwSectionHWID="nord723-Header";var hwSource="en-caQ2_05";var hwDocType="Nord"; National Organization for Rare Disorders, Inc. Anemia, Hemolytic, Cold Antibody Important It is possible that the main title of the report Anemia, Hemolytic, Cold Antibody is not the name you expected. Please check the synonyms listing to find the alternate name(s) and disorder subdivision(s) covered by this report. Synonyms Anemia, Autoimmune Hemolytic Cold Agglutinin Disease Cold Antibody Disease Disorder Subdivisions None General Discussion Cold Antibody Hemolytic Anemia is a rare autoimmune disorder characterized by the premature destruction of red blood cells by the body's natural defenses against invading organisms (antibodies). Normally, the red blood cells have a life span of approximately 120 days before they are removed by the spleen. In individuals with Cold Antibody Hemolytic Anemia, the red blood cells are destroyed prematurely and bone marrow production of new cells can no longer compensate for their loss. The severity of the anemia is determined by the length of time that the red blood cells survive and by the capacity of the bone marrow to continue new red blood cell production. Immune Hemolytic Anemias may be subdivided by the temperatures at which the antibodies destroy red blood cells. As its name implies, Cold Antibody Hemolytic Anemia occurs at temperatures of approximately to 10 degrees centigrade (while Warm Antibody Hemolytic Anemia, for example, occurs at temperatures of 37 degrees or higher).

A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z

Page 4     61-80 of 109    Back | 1  | 2  | 3  | 4  | 5  | 6  | Next 20